Program Description
Metabolic dysfunction-associated steatohepatitis (MASH) is a severe,
inflammatory form of liver disease associated with various metabolic
comorbidities, such as type 2 diabetes and obesity. A growing understanding of
disease pathogenesis has contributed to the emergence and recent therapy
approvals, including THR-β agonists and GLP-1 receptor agonists, that target
fibrotic and metabolic pathways. As the prevalence of MASH continues to rise
alongside an evolving treatment landscape, pharmacists are positioned to
provide and optimize comprehensive care for patients with MASH. This activity
will discuss disease-modifying intervention strategies to reduce the clinical
burden associated with MASH, emphasizing the early identification and management
of underlying cardiometabolic risk factors. Challenges navigating access to
MASH therapies, key patient counseling considerations related to lifestyle
modifications and medication use, and approaches to coordinating safe
multidisciplinary care will be addressed to support improved patient outcomes. This symposium is the third in the MASLD/MASH curriculum
Target audience: Specialty
and health-system pharmacists
Type of activity: Application
Release date: May 31, 2026
Expiration date: May 31, 2027
Learner level: Foundational
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain the role of the pharmacist in improving care and outcomes for patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)
- Identify common barriers to care in MASH, including insurance coverage and access challenges, to ensure timely initiation of approved and emerging therapies
- Construct a multidisciplinary monitoring plan that tracks treatment response, safety, and long-term cardiometabolic risk reduction for patients receiving MASH pharmacotherapy
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here